Literature DB >> 16813133

[Influenza, an existing public health problem].

Juan García-García1, Celso Ramos.   

Abstract

Seasonal influenza is an acute and recurring respiratory disease known since ancient times, occuring, in particular, during winter months and having an elevated effect on public health worldwide. The disease has high morbidity rates for people of all ages and particularly high mortality rates for children, adults over 60 years old, patients with chronic illnesses and pregnant women. Prevention control strategies include vaccination using inactivated, subunit or genetically modified virus vaccines. Influenza in humans is caused by two subtypes of influenza virus A and one of influenza virus B. The influenza virus A that affects humans mutates easily, thereby often causing new antigenic variants of each subtype to emerge, requiring the inclusion of such variants in annual vaccines in order to assure proper immunization of the population. The influenza pandemic refers to the introduction and later worldwide spread of a new influenza virus in the human population, which occurs sporadically. Due to the lack of immunity in humans against the new virus, serious epidemics can be provoked resulting in high morbidity and mortality rates. Historically, influenza pandemics are a result of the transmission of the virus from birds to humans, or the transfer of such genes to seasonal influenza. Wild waterfowl--both migratory and shore birds--carry a large diversity of influenza virus subtypes, which are eventually transmitted to domestic birds. Some of those viruses cross the species barrier and infect mammals, including humans. The adaptation process of the avian virus to mammal hosts requires time. Therefore, the presentation of these cases can take several years. Since December 2003, in several Southeast Asian countries a large proportion of domestic birds have been affected by an avian influenza epidemic (subtype H5N1). By Februrary 2006, the epidemic had already affected countries in Europe and Africa, having a significant economic impact on commercial poultry due to the more than 180 million birds that were sacrificed. Some strains of this avian influenza virus have directly, although incipiently, infected the human population. The virus has not yet acquired with complete efficiency person-to-person infection and transmission, which has limited its spread among humans. Since the mortality rate in infected individuals is greater than 50%, the World Health Organization (WHO) called on their member countries to establish preparation and emergency plans against the threat of a possible pandemic associated with H5N1 virus, or another virus related to common influenza. These actions are intended to prevent or reduce the impact of the threat, as experienced in previous pandemics, such as in 1918 when roughly 40 million people died worldwide. The prevention and control plans include, among other strategies, vaccination and antiviral medications. Nevertheless, to date there are no vaccines to be administered to the population in the case of a new influenza pandemic emergency and it is possible that countries that produce the annual seasonal influenza vaccine lack the capacity to produce the pandemic virus vaccine in a short period of time. In addition, recent studies have identified the existence of influenza virus strains resistant to common antiviral agents. The purpose of this review is to update the basic concepts of influenza in order to strengthen epidemiological surveillance of the disease and reinitiate prevention and control actions in the event of a pandemic.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16813133     DOI: 10.1590/s0036-36342006000300009

Source DB:  PubMed          Journal:  Salud Publica Mex        ISSN: 0036-3634


  10 in total

1.  Influenza-like illness sentinel surveillance in Peru.

Authors:  V Alberto Laguna-Torres; Jorge Gómez; Víctor Ocaña; Patricia Aguilar; Tatiana Saldarriaga; Edward Chavez; Juan Perez; Hernán Zamalloa; Brett Forshey; Irmia Paz; Elizabeth Gomez; Roel Ore; Gloria Chauca; Ernesto Ortiz; Manuel Villaran; Stalin Vilcarromero; Claudio Rocha; Omayra Chincha; Gerardo Jiménez; Miguel Villanueva; Edwar Pozo; Jackeline Aspajo; Tadeusz Kochel
Journal:  PLoS One       Date:  2009-07-01       Impact factor: 3.240

2.  The role of initial radiologic and clinical manifestations in predicting the prognosis for pneumonia caused by H1N1 influenza virus.

Authors:  Cemil Göya; Alpaslan Yavuz; Cihad Hamidi; Mehmet Güli Cetinçakmak; Memik Teke; Salih Hattapoğlu; Abdurrahim Duşak
Journal:  J Thorac Dis       Date:  2014-06       Impact factor: 2.895

3.  Protective Effect of Panax notoginseng Root Water Extract against Influenza A Virus Infection by Enhancing Antiviral Interferon-Mediated Immune Responses and Natural Killer Cell Activity.

Authors:  Jang-Gi Choi; Young-Hee Jin; Heeeun Lee; Tae Woo Oh; Nam-Hui Yim; Won-Kyung Cho; Jin Yeul Ma
Journal:  Front Immunol       Date:  2017-11-13       Impact factor: 7.561

4.  Radiological findings of pneumonia in patients with swine-origin influenza A virus (H1N1).

Authors:  E Busi Rizzi; V Schininà; F Ferraro; L Rovighi; M Cristoforo; D Chiappetta; F Lisena; F Lauria; C Bibbolino
Journal:  Radiol Med       Date:  2010-06-05       Impact factor: 3.469

Review 5.  MicroRNAs in Asthma and Respiratory Infections: Identifying Common Pathways.

Authors:  Styliani Taka; Panayiota Tzani-Tzanopoulou; Hannah Wanstall; Nikolaos G Papadopoulos
Journal:  Allergy Asthma Immunol Res       Date:  2020-01       Impact factor: 5.764

6.  Baicalin inhibits influenza virus A replication via activation of type I IFN signaling by reducing miR‑146a.

Authors:  Rui Li; Lianxin Wang
Journal:  Mol Med Rep       Date:  2019-10-15       Impact factor: 2.952

7.  Occurrence of AH1N1 viral infection and clinical features in symptomatic patients who received medical care during the 2009 influenza pandemic in Central Mexico.

Authors:  Juan Pablo Castillo-Palencia; Lucie Laflamme; Joel Monárrez-Espino
Journal:  BMC Infect Dis       Date:  2012-12-20       Impact factor: 3.090

Review 8.  Combined inhalational and oral supplementation of ascorbic acid may prevent influenza pandemic emergency: a hypothesis.

Authors:  Dibyajyoti Banerjee; Deepak Kaul
Journal:  Nutrition       Date:  2010-01       Impact factor: 4.008

Review 9.  microRNAs in viral acute respiratory infections: immune regulation, biomarkers, therapy, and vaccines.

Authors:  Stephen A Leon-Icaza; Mingtao Zeng; Adrian G Rosas-Taraco
Journal:  ExRNA       Date:  2019-02-14

Review 10.  Pregnancy and pandemics: Interaction of viral surface proteins and placenta cells.

Authors:  Paulina Fuentes-Zacarías; Jose M Murrieta-Coxca; Ruby N Gutiérrez-Samudio; Astrid Schmidt; Andre Schmidt; Udo R Markert; Diana M Morales-Prieto
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2021-07-24       Impact factor: 6.633

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.